Supplier profile
Swedish Orphan Biovitrum GmbH
Every public-sector award we hold for this supplier, across Germany, from 11 Jul 2024 to 23 Sept 2026.
Awards won
11
all time
Attributed value
€8
1 shared, unvalued
Buyers
6
public bodies
Active
2024–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| IKK classic | 4 | €4 |
| AOK Bayern - Die Gesundheitskasse | 2 | not attributable |
| AOK Sachsen - Anhalt | 2 | €2 |
| AOK Baden-Württemberg | 1 | not attributable |
| DAK-Gesundheit | 1 | €1 |
| GWQ ServicePlus AG | 1 | €1 |
What they win
Awards
All 11 awards we hold
- Germany – Pharmaceutical products – Vereinbarung gemäß § 130c Abs. 1 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit dem Wirkstoff Eftrenonacog alfa (Alprolix®) ↗AOK Baden-Württembergshared awardawarded 23 Sept 2026
- Germany – Pharmaceutical products – Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Alprolix (B02BD04), Elocta (B02BD02) und Altuvoct (B02BD02) zur Behandlung der Hämophilie ↗AOK Sachsen - Anhalt€1awarded 3 Sept 2026
- Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Alprolix (B02BD04), Elocta (B02BD02) und Altuvoct (B02BD02) zur Behandlung der Hämophilie ↗AOK Sachsen - Anhalt€1awarded 2 Sept 2026
- Ex-Ante-Transparenzbekanntmachung § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V ATC-Code: B02BD34; ATC-Code: B02BD32; ATC-Code B02BD45 ↗AOK Bayern - Die Gesundheitskasseawarded 23 Jul 2026
- Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Abs. 8 bzw. § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Aspaveli (Wirkstoff: Pegcetacoplan), ATC L04AJ03 ↗DAK-Gesundheit€1awarded 17 Jun 2026
- Germany – Pharmaceutical products – Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Swedish Orphan Biovitrum GmbH zu Aspaveli ↗IKK classic€1awarded 28 May 2026
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Swedish Orphan Biovitrum GmbH zu Aspaveli ↗IKK classic€1awarded 27 May 2026
- Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 c AGB V zu dem Arzneimittel Pegcetacoplan (Aspaveli) ↗GWQ ServicePlus AG€1awarded 1 Apr 2026
- Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Aspaveli(R) Wirkstoff: Pegcetacoplan ATC-Code: L04AJ03 ↗AOK Bayern - Die Gesundheitskasseawarded 17 Mar 2026
- Germany – Pharmaceutical products – Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Swedish Orphan Biovitrum GmbH zu Altuvoct, Alprolix & Elocta ↗IKK classic€1awarded 12 Jul 2024
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Swedish Orphan Biovitrum GmbH zu Altuvoct, Alprolix & Elocta ↗IKK classic€1awarded 11 Jul 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Swedish Orphan Biovitrum (SOBI)7 awards · £270k
- SWEDISH ORPHAN BIOVITRUM, S.L.179 awards
- SWEDISH ORPHAN BIOVITRUM79 awards
- Swedish Orphan Biovitrum AB (publ)56 awards
- SWEDISH ORPHAN BIOVITRUM S.R.L.54 awards
- Swedish Orphan Biovitrum A/S45 awards
- Swedish Orphan Biovitrum, S.L. (SOBI)18 awards
- Swedish Orphan Biovitrum AB14 awards
- Swedish Orphan Biovitrum Ltd (Sobi UK)4 awards
- Swedish Orphan Biovitrum, S.L.U.2 awards
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative. Profiles may take up to an hour to reflect newly collected records.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.